Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Cor Therapeutics receives milestone for Integrilin MAA review

Feb. 23, 1998

FDA accepts The Medicines Company's NDA for Hirulog

Feb. 20, 1998

Xenova, Lilly collaborate on new antithrombotics

Feb. 20, 1998

Lilly claims thrombin inhibitors

Feb. 19, 1998

New cell adhesion inhibitors from Shionogi

Feb. 19, 1998

Centocor to acquire rights to reteplase in U.S., Canada

Feb. 18, 1998

Tsetse thrombin inhibitor isolated, purified and characterized at Yale

Feb. 18, 1998

Canadian market introduction for Fraxiparine announced

Feb. 10, 1998

Lovenox approved for at-home use in U.S.

Feb. 9, 1998

Anticoagulant apoB-100 fragment discovered at Royal Free Hospital

Feb. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.